Reaktion #520223
ord-ddc4957015ec40468e02a4a583b75244
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1Sonstigeto produce a 1 mg/ml stock solution
- 2FiltrationThe stock was filtered through 0.8 μm nylon
- 3SonstigeFor individual assays, an intermediate stock was prepared by thawing
- 4workup.ADDITIONdiluting an aliquot with RPMI-1640+10% Fetal Calf Serum (FCS) such that
- 5Sonstigewould produce a final concentration of 8 μg/ml
- 6Sonstigereaction with endogenous enzymes in the FCS (which
- 7Temperaturcould increase the background fluorescence
Vorschrift
Fluorescein diacetate (FDA) (Sigma Chemical Co., St. Louis, Mo.), or 2′,7′-bis-(2-carboxyethyl)-5(and-6) carboxyfluorescein, acetoxymethyl ester (BCECF-AM) (Molecular Probes, Inc., Eugene, Oreg.) was dissolved in dimethyl sulfoxide (DMSO) to produce a 1 mg/ml stock solution. The stock was filtered through 0.8 μm nylon, aliquoted into 1.5 ml microfuge tubes and stored frozen at −20° C. in the dark. For individual assays, an intermediate stock was prepared by thawing and diluting an aliquot with RPMI-1640+10% Fetal Calf Serum (FCS) such that adding 50 μl of dye solution to a well would produce a final concentration of 8 μg/ml. To minimize reaction with endogenous enzymes in the FCS (which could increase the background fluorescence by cleaving ester groups to form free fluorescein), intermediate dilutions were prepared immediately prior to loading each individual plate.